Regulatory Compliance Response from Ortin Global Limited
Date of Communication: 09.07.2026
Nature of Query: The National Stock Exchange of India Limited (NSE) raised a query dated 27.06.2026 regarding the company's financial results for the quarter and year ended 31.03.2026. Specifically, the exchange noted that segment details had not been submitted.
Company's Clarification: In response to Query 1 regarding missing segment details, Ortin Global Limited clarified that "The requirement relating to segment details is not applicable to the Company, as the company operates in only one segment i.e., Drugs and Medicines." This indicates that the company's business activities are concentrated solely within the pharmaceutical manufacturing sector, making segment-wise reporting redundant under applicable accounting standards.
Regulatory Compliance: This communication serves as a formal response to the NSE query and represents compliance with regulatory requirements, likely under Regulation 30 of the SEBI Listing Obligations and Disclosure Requirements, which mandates timely disclosure of material information and responses to exchange queries.
Topic Tags: Regulatory Response, Financial Results Clarification, Compliance, Segment Reporting